These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6116236)

  • 1. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
    Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
    Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the effects of anthracyclines on mitochondrial respiration in vitro.
    Solaini G; Ronca G; Bertelli A
    Drugs Exp Clin Res; 1985; 11(2):115-21. PubMed ID: 3869803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between effects of anthracyclines on in vitro cardiac guanyl cyclase and in vivo cardiotoxicity.
    Zbinden G
    Cancer Treat Rep; 1982 Aug; 66(8):1677-8. PubMed ID: 6125261
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory effects of several anthracyclines on mitochondrial respiration and coenzyme Q10 protection.
    Solaini G; Ronca G; Bertelli A
    Drugs Exp Clin Res; 1985; 11(8):533-7. PubMed ID: 3869924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin, aclacinomycin and thepirubicin intracardiac distribution examined by fluorescence microscopy.
    Scalori V; Alessandrì MG; Giovannini L; Bertelli AA; Mian M
    Chemioterapia; 1988 Jun; 7(3):179-83. PubMed ID: 3168073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.
    Bhuyan BK; McGovren JP; Crampton SL
    Cancer Res; 1981 Mar; 41(3):882-7. PubMed ID: 6450639
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of rat and human cardiac guanylate cyclase in vitro by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
    Levey GS; Levey BA; Ruiz E; Lehotay DC
    J Mol Cell Cardiol; 1979 Jun; 11(6):591-9. PubMed ID: 37344
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
    Marzin D; Jasmin C; Maral R; Mathe G
    Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of aclacinomycin B on DNA polymerase II of tumor cells].
    Li ZR; Feng JB; Han R; Yin MB; Xia LJ
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):189-92. PubMed ID: 2943125
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differentiation of human promyelocytic leukemic cells (HL-60) induced by aclacinomycin-B].
    Lu Y; Han J; Liu HY; Zhong GP; Yang S; Jia TZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):211-3. PubMed ID: 2946461
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
    Li ZR; Feng JB; Liang F; Zeng SX; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
    Skovsgaard T
    Eur J Haematol Suppl; 1987; 47():7-20. PubMed ID: 3552720
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of aclacinomycin B on nucleolar ultrastructure and function of RNA synthesis in human gastric cancer cells].
    Li LH; Wang YS; Li GR
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):266-71. PubMed ID: 2959026
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.